AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
185,70 € ↓ -2,40 (-1,28%)
2026-06-02
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionWealthfront Advisers Llc
Latest Disclosed Ownership182,934 shares
Latest Disclosed Value $ 39,786,316
Wealthfront Advisers Llc reports 1.63% increase in ownership of 4AB / AbbVie Inc.

On May 5, 2026 - Wealthfront Advisers Llc filed a 13F-HR form disclosing ownership of 182,934 shares of AbbVie Inc. (DE:4AB) valued at $33,915,964 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 180,003 shares of AbbVie Inc.. This represents a change in shares of 1.63% during the quarter. The current value of the position is $33,970,844 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F ABBVIE COM 00287Y109 182,934 2,931 1.63 39,786 -3.26 0.0873
2026-01-30 2025-12-31 13F ABBVIE COM 00287Y109 180,003 4,603 2.62 41,129 1.27 0.0919
2025-11-06 2025-09-30 13F ABBVIE COM 00287Y109 175,400 14,845 9.25 40,612 36.27 0.0953
2025-07-31 2025-06-30 13F ABBVIE COM 00287Y109 160,555 -268 -0.17 29,802 -11.55 0.0767
2025-05-02 2025-03-31 13F ABBVIE COM 00287Y109 160,823 11,726 7.86 33,696 27.18 0.0905
2025-04-01 2024-12-31 13F/A-1 ABBVIE COM 00287Y109 149,097 9,608 6.89 26,495 -3.82 0.0774
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 139,489 5,380 4.01 27,546 19.75 0.0847
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 134,109 -3,744 -2.72 23,002 -8.37 0.0774
2024-04-19 2024-03-31 13F ABBVIE COM 00287Y109 137,853 6,615 5.04 25,103 23.44 0.0878
2024-02-09 2023-12-31 13F ABBVIE COM 00287Y109 131,238 -11,104 -7.80 20,338 -4.15 0.0781
2023-11-01 2023-09-30 13F ABBVIE COM 00287Y109 142,342 16,107 12.76 21,217 24.75 0.0914
2023-08-07 2023-06-30 13F ABBVIE COM 00287Y109 126,235 -57,358 -31.24 17,008 -41.87 0.0721
2023-04-28 2023-03-31 13F ABBVIE COM 00287Y109 183,593 -2,081 -1.12 29,259 -2.49 0.1330
2023-02-10 2022-12-31 13F ABBVIE COM 00287Y109 185,674 12,451 7.19 30,007 29.07 0.1454
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 173,223 8,913 5.42 23,248 -7.62 0.1236
2022-07-20 2022-06-30 13F ABBVIE COM 00287Y109 164,310 23,252 16.48 25,166 10.05 0.1265
2022-05-16 2022-03-31 13F ABBVIE COM 00287Y109 141,058 13,043 10.19 22,867 31.92 0.1002
2022-01-21 2021-12-31 13F ABBVIE COM 00287Y109 128,015 10,538 8.97 17,334 36.78 0.0733
2021-11-15 2021-09-30 13F ABBVIE COM 00287Y109 117,477 15,313 14.99 12,673 10.12 0.0587
2021-08-16 2021-06-30 13F ABBVIE COM 00287Y109 102,164 9,608 10.38 11,508 14.90 0.0547
2021-05-14 2021-03-31 13F ABBVIE COM 00287Y109 92,556 3,997 4.51 10,016 5.55 0.0536
2021-02-16 2020-12-31 13F ABBVIE COM 00287Y109 88,559 -7,449 -7.76 9,489 12.84 0.0571
2020-11-16 2020-09-30 13F ABBVIE COM 00287Y109 96,008 -8,382 -8.03 8,409 -17.95 0.0601
2020-08-14 2020-06-30 13F ABBVIE COM 00287Y109 104,390 15,628 17.61 10,249 51.55 0.0795
2020-05-15 2020-03-31 13F ABBVIE COM 00287Y109 88,762 18,730 26.74 6,763 9.06 0.0614
2020-01-21 2019-12-31 13F ABBVIE COM 00287Y109 70,032 6,862 10.86 6,201 29.65 0.0460
2019-10-15 2019-09-30 13F ABBVIE COM 00287Y109 63,170 5,492 9.52 4,783 14.04 0.0401
2019-08-13 2019-06-30 13F ABBVIE COM 00287Y109 57,678 -4,222 -6.82 4,194 -15.94 0.0364
2019-05-13 2019-03-31 13F ABBVIE COM 00287Y109 61,900 -28,507 -31.53 4,989 -40.14 0.0463
2019-02-14 2018-12-31 13F ABBVIE COM 00287Y109 90,407 90,407 8,335 0.0886
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.